Univariate Cox regression analysis demonstrated that decreased mRNA expression of BRD4 was associated with decreased OS (HR = 2.034, 95% CI 1.009–4.102, p = 0.047) in the TCGA endometrial cancer cohort however this did not remain significant in a multivariate models (Supplementary Table S2). Here, BRD4 is linked to endometrial cancer.